New Report on Neuropathic Pain Global Clinical Trials Review, H1, 2014

189 views

Published on

Neuropathic Pain Global Clinical Trials Review, H1, 2014 @

Published in: Health & Medicine, Business
  • Be the first to comment

  • Be the first to like this

New Report on Neuropathic Pain Global Clinical Trials Review, H1, 2014

  1. 1. Neuropathic Pain Global Clinical Trials Review, H1, 2014 Neuropathic Pain Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, Neuropathic Pain Global Clinical Trials Review, H1, 2014" provides data on the Neuropathic Pain clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Neuropathic Pain. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Neuropathic Pain. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Reasons to buy - Understand the dynamics of a particular indication in a condensed manner - Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more - Obtain discontinued trial listing for trials across the globe - Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies Table Of Contents table Of Contents 2 list Of Tables 4 list Of Figures 5 introduction 6 neuropathic Pain 6 report Guidance 6 clinical Trials By Region 7 clinical Trials And Average Enrollment By Country 8 top Five Countries Contributing To Clinical Trials In Asia-pacific 10 top Five Countries Contributing To Clinical Trials In Europe 11 top Countries Contributing To Clinical Trials In North America 12 top Five Countries Contributing To Clinical Trials In Middle East And Africa 13 top Five Countries Contributing To Clinical Trials In Central And South America 14 clinical Trials By G7 Countries: Proportion Of Neuropathic Pain To Central Nervous System Clinical Trials 15 clinical Trials By Phase In G7 Countries 16 clinical Trials In G7 Countries By Trial Status 17 clinical Trials By E7 Countries: Proportion Of Neuropathic Pain To Central Nervous System Clinical Trials 18 clinical Trials By Phase In E7 Countries 19 clinical Trials In E7 Countries By Trial Status 20 clinical Trials By Phase 21 in Progress Trials By Phase 22 clinical Trials By Trial Status 23 clinical Trials By End Point Status 24 unaccomplished Trials Of Neuropathic Pain 25 subjects Recruited Over A Period Of Time 32 clinical Trials By Sponsor Type 33 prominent Sponsors 34 top Companies Participating In Neuropathic Pain Therapeutics Clinical Trials 35 prominent Drugs 36 latest Clinical Trials News On Neuropathic Pain 37 may 05, 2014: Immune Pharmaceuticals Announces Phase 3 Development And Commercialization Strategy For Amiket 37 clinical Trial Profiles 38 clinical Trial Overview Of Top Companies 38 pfizer Inc. 38 clinical Trial Overview Of Pfizer Inc. 38 astrazeneca Plc 44 clinical Trial Overview Of Astrazeneca Plc 44 Neuropathic Pain Global Clinical Trials Review, H1, 2014
  2. 2. grunenthal Gmbh 46 clinical Trial Overview Of Grunenthal Gmbh 46 glaxosmithkline Plc 48 clinical Trial Overview Of Glaxosmithkline Plc 48 eli Lilly And Company 49 clinical Trial Overview Of Eli Lilly And Company 49 neurogesx, Inc. 50 clinical Trial Overview Of Neurogesx, Inc. 50 gw Pharmaceuticals Plc 51 clinical Trial Overview Of Gw Pharmaceuticals Plc 51 spinifex Pharmaceuticals Pty Limited 52 clinical Trial Overview Of Spinifex Pharmaceuticals Pty Limited 52 endo International Plc 53 clinical Trial Overview Of Endo International Plc 53 abbvie Inc. 54 clinical Trial Overview Of Abbvie Inc. 54 clinical Trial Overview Of Top Institutes / Government 55 university Hospital, Clermont-ferrand 55 clinical Trial Overview Of University Hospital, Clermont-ferrand 55 lawson Health Research Institute 56 clinical Trial Overview Of Lawson Health Research Institute 56 rigshospitalet 57 clinical Trial Overview Of Rigshospitalet 57 leiden University Medical Center 58 clinical Trial Overview Of Leiden University Medical Center 58 danish Pain Research Center 59 clinical Trial Overview Of Danish Pain Research Center 59 rambam Health Care Campus 60 clinical Trial Overview Of Rambam Health Care Campus 60 university Of Manitoba 61 clinical Trial Overview Of University Of Manitoba 61 university Of California, San Francisco 62 clinical Trial Overview Of University Of California, San Francisco 62 u.s. Department Of Veterans Affairs 63 clinical Trial Overview Of U.s. Department Of Veterans Affairs 63 capital District Health Authority, Canada 64 clinical Trial Overview Of Capital District Health Authority, Canada 64 five Key Clinical Profiles 65 appendix 176 abbreviations 176 definitions 176 research Methodology 177 secondary Research 177 about Globaldata 178 contact Us 178 disclaimer 178 source 178 list Of Tables neuropathic Pain Therapeutics, Global, Clinical Trials By Region, 2014* 7 neuropathic Pain Therapeutics, Global, Clinical Trials And Average Enrollment By Top Countries, 2014* 8 neuropathic Pain Therapeutics, Global, Clinical Trials In Progress By Top Countries, 2014* 9 neuropathic Pain Therapeutics Clinical Trials, Asia-pacific, Top Five Countries, 2014* 10 neuropathic Pain Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11 neuropathic Pain Therapeutics Clinical Trials, North America, Top Countries, 2014* 12 neuropathic Pain Therapeutics Clinical Trials, Middle East And Africa, Top Five Countries, 2014* 13 neuropathic Pain Therapeutics Clinical Trials, Central And South America, Top Five Countries, 2014* 14 proportion Of Neuropathic Pain To Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15 neuropathic Pain Therapeutics, G7 Countries, Clinical Trials By Phase, 2014* 16 neuropathic Pain Therapeutics, G7 Countries, Clinical Trials By Trial Status, 2014* 17 proportion Of Neuropathic Pain To Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18 neuropathic Pain Therapeutics, E7 Countries, Clinical Trials By Phase, 2014* 19 neuropathic Pain Therapeutics, E7 Countries, Clinical Trials By Trial Status, 2014* 20 neuropathic Pain Therapeutics, Global, Clinical Trials By Phase, 2014* 21 neuropathic Pain Therapeutics, Global, Clinical Trials In Progress By Phase 2014* 22 neuropathic Pain Therapeutics, Global, Clinical Trials By Trial Status, 2014* 23 neuropathic Pain Therapeutics Clinical Trials, Global, By End Point Status, 2014* 24 neuropathic Pain Therapeutics, Global, Suspended Clinical Trials, 2014* 25 Neuropathic Pain Global Clinical Trials Review, H1, 2014
  3. 3. neuropathic Pain Therapeutics, Global, Withdrawn Clinical Trials, 2014* 26 neuropathic Pain Therapeutics, Global, Terminated Clinical Trials, 2014* 27 neuropathic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32 neuropathic Pain Therapeutics Market, Global, Clinical Trials By Sponsor Type, 2014* 33 neuropathic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34 neuropathic Pain Therapeutics Clinical Trials, Global, Top Companies By Phase, 2014* 35 neuropathic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials By Prominent Drugs, 2014* 36 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Pfizer Inc., 2014* 38 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Astrazeneca Plc, 2014* 44 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Grunenthal Gmbh, 2014* 46 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Glaxosmithkline Plc, 2014* 48 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Eli Lilly And Company, 2014* 49 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Neurogesx, Inc., 2014* 50 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Gw Pharmaceuticals Plc, 2014* 51 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Spinifex Pharmaceuticals Pty Limited, 2014* 52 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Endo International Plc, 2014* 53 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Abbvie Inc., 2014* 54 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By University Hospital, Clermont-ferrand, 2014* 55 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Lawson Health Research Institute, 2014* 56 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Rigshospitalet, 2014* 57 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Leiden University Medical Center, 2014* 58 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Danish Pain Research Center, 2014* 59 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Rambam Health Care Campus, 2014* 60 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By University Of Manitoba, 2014* 61 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By University Of California, San Francisco, 2014* 62 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By U.s. Department Of Veterans Affairs, 2014* 63 neuropathic Pain Therapeutics Clinical Trials Market, Global, Clinical Trials By Capital District Health Authority, Canada, 2014* 64 list Of Figures neuropathic Pain Therapeutics, Global, Clinical Trials By Region (%), 2014* 7 neuropathic Pain Therapeutics, Global, Clinical Trials And Average Enrollment By Top Countries, 2014* 8 neuropathic Pain Therapeutics, Global, Clinical Trials In Progress By Top Countries, 2014* 9 neuropathic Pain Therapeutics Clinical Trials, Asia-pacific, Top Five Countries (%), 2014* 10 neuropathic Pain Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11 neuropathic Pain Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12 neuropathic Pain Therapeutics Clinical Trials, Middle East And Africa, Top Five Countries (%), 2014* 13 neuropathic Pain Therapeutics Clinical Trials, Central And South America, Top Five Countries (%), 2014* 14 proportion Of Neuropathic Pain To Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15 neuropathic Pain Therapeutics, G7 Countries, Clinical Trials By Phase, 2014* 16 neuropathic Pain Therapeutics, G7 Countries, Clinical Trials By Trial Status, 2014* 17 proportion Of Neuropathic Pain To Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18 neuropathic Pain Therapeutics, E7 Countries, Clinical Trials By Phase, 2014* 19 neuropathic Pain Therapeutics, E7 Countries, Clinical Trials By Trial Status, 2014* 20 neuropathic Pain Therapeutics, Global, Clinical Trials By Phase (%), 2014* 21 neuropathic Pain Therapeutics, Global, Clinical Trials In Progress By Phase, 2014* 22 neuropathic Pain Therapeutics, Global, Clinical Trials By Trial Status, 2014* 23 neuropathic Pain Therapeutics Clinical Trials, Global, By End Point Status, 2014* 24 neuropathic Pain Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 32 neuropathic Pain Therapeutics Market, Global, Clinical Trials By Sponsor Type (%), 2014* 33 neuropathic Pain Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 34 neuropathic Pain Therapeutics Clinical Trials, Global, Top Companies By Phase, 2014* 35 neuropathic Pain Therapeutics Clinical Trials, Global, Ongoing Clinical Trials By Prominent Drugs, 2014* 36 globaldata Methodology 177 ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price. Contact: M/s Sheela, 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-997-4948 Email: sales@researchmoz.us Neuropathic Pain Global Clinical Trials Review, H1, 2014
  4. 4. Website: http://www.researchmoz.us/ Neuropathic Pain Global Clinical Trials Review, H1, 2014

×